Prestige BioPharma950210 
$10.181.12%24h
1.12%24h
Global rank10247
Market cap$608.99M
Change 7d2.66%
YTD Performance41.36%
SP500 benchmarkOutperform
P/E0.03
P/S4991.64
Revenue$122.00K
Earnings-$2.16M
Dividend yield-
Prestige BioPharma (950210) Cash on Hand
950210 Cash on Hand in 2022: $227.22M
According to Prestige BioPharma latest financial reports the cash on hand of 950210 is $227.22M, an decrease of -0.61% to 2022. At the end of 2022 company had $228.62M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
950210 Cash on Hand History from 2020 to 2023
-
Value:-
950210 Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $227.22M | -0.61% |
| 2022 | $228.62M | -33.98% |
| 2021 | $346.28M | 849.10% |
| 2020 | $36.49M | - |
View the Top Cash on Hand Companies 
